🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
31Score
DipBuster Score™
$184.03
+$0.39 (+0.21%)
Live price · Source: Yahoo
52-Week Position
$101.00
57% of range
$247.49
Beta
0.795
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.795
52W High$247.49
52W Low$101.00
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (57% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position57% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.795
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at DaVita Inc. (DVA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-09-22 | Maughan David Paul | SELL | 7,501 |
| 2026-08-15 | Pullin Dennis W | BUY | 278 |
| 2026-08-15 | Moore Gregory J. | BUY | 278 |
| 2026-08-15 | Hollar Jason M. | BUY | 278 |
| 2026-08-15 | Arway Pamela M | BUY | 278 |
| 2026-08-15 | Schechter Adam H | BUY | 278 |
| 2026-08-15 | Schoppert Wendy Lee | BUY | 278 |
| 2026-08-15 | Yale Phyllis R | BUY | 278 |
| 2026-08-15 | Desoer Barbara J | BUY | 278 |
| 2026-07-31 | Berkshire Hathaway Inc | SELL | 182,980 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.795
Dividend/yrNone
52W High$247.49
52W Low$101.00
52-Week Range
$101.00Now$247.49
57% through annual range
From 52W High−25.6%
From 52W Low+82.2%
📖 Plain English Summary
DaVita Inc. is at 57% of its 52-week range. Beta 0.795 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for DVA
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — DVA
Heuristic · balance sheet, insider filings, price data, academic research
DaVita Inc. — DipBuster Score 31/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track DaVita Inc. free
Add DVA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
17/25
Momentum & Volume
9/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
6
/100 · NEUTRAL
dip depth
4/25
oversold rsi
2/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 31/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpati…
Sector
Healthcare
Market
🇺🇸 US
CEO
Javier J. Rodriguez
Staff
78,000 employees
Website